Noah Medical develops medical robotic solutions for earlier diagnosis with greater confidence, focusing on interventional pulmonology. The company collaborates with interventional pulmonologists to create medical device engineering, robotics, software, and clinical applications.

Noah Medical

Cyber Surgery develops innovative robotic assistants for seamless spinal procedures, focusing on surgical planning and vertebral fusion.

Cyber Surgery

Zimmer Biomet develops and provides medical technology solutions aimed at alleviating pain and improving the quality of life for people around the world. Self-described as committed to advancing healthcare through cutting-edge technology.

Zimmer Biomet

Noah Medical is building the future of medical robotics. Our next generation robotic platform targets early diagnosis and treatment of patients across multiple indications.

Based in Silicon Valley and backed by well-known institutional investors, our incredibly talented team of 70+ engineers, innovators and industry leaders brings years of experience from the top healthcare companies in the world.

Hillhouse Capital

1955 Capital

Prosperity7 Ventures

Sequoia Capital China

Shangbay Capital

Tiger Global Management

UpHonest Capital

Lenovo Capital and Incubator Group (LCIG)

LYFE Capital

Ying Fund

AME Cloud Ventures

SoftBank Vision Fund

Dr. D. Kyle Hogarth, MD, FCCP with an excellent example of how The Galaxy System™ with TiLT+ Technology™ is helping him and his team UChicago Medicine overcome CT-to-body divergence, improve overall diagnostic yield and provide positive patient outcomes.
 
This proprietary technology is designed to allow for real-time navigation updates and guidance in all areas of the lung, including an augmented fluoro feature designed to overlay a graphical representation of the target lesion during live fluoro video to help locate non-visual lesions.

#NoahMedical #GalaxySystem #AlwaysInSight #LungCancer #Bronchoscopy #iiRAB #healthcare

The final results and high diagnostic yield from Noah Medical’s FRONTIER Study were recently covered by Healio. https://hubs.ly/Q02H7CRf0

Originally published in the Official Journal of the Asian Pacific Society of Respirology, the study found that Galaxy achieved 100% successful navigation to small lesions in the lung periphery, diagnostic yield up to 94.7% (intermediate) and 100% tool-in-lesion accuracy. Importantly, this study is also noteworthy because it demonstrates that the use of Galaxy can be rapidly scaled to improve lung cancer detection rates even in places where physicians have limited experience with robotic systems. Thanks to Dr. Tajalli Saghaie for his important work in completing this clinical trial.

#NoahMedical #LungCancer #RoboticBronchoscopy #EarlyDetection #DiagnosticYield

“CT-to-body divergence has been an issue we’ve known about for the past three years. And we’ve all seen this. You try to biopsy a nodule, and you’re there, and suddenly on a fluoroscopy image, the green dot is outside the CT scan, and on the fluoro, you’re still in the lung. There have been other ways for us to try to combat this with different add-on imaging. What we need is a system that combines all that into one and that is the Galaxy.” - Gautam Balakrishnan, MD, FCCP

Only the Galaxy System™ with TiLT+ Technology™ provides Integrated Tomosynthesis to overcome CT-to-body divergence.  Learn more: https://hubs.ly/Q02GbmnT0

#NoahMedical #GalaxySystem #LungCancer #Bronchoscopy #iiRAB #healthcare

Congratulations Dr. PRAVACHAN HEGDE & your team at Community Health System for completing your 100th Galaxy Case! Thank you for your continued partnership and pioneering being one of the FIRST & ONLY in the U.S. to utilize The Galaxy System™ helping patients obtain early lung cancer diagnosis!! 

#FirstandOnly #NoahMedical #GalaxySystem #LungCancer #Bronchoscopy #iiRAB #healthcare

Dr. PRAVACHAN HEGDE of Community Health System recently sat down with Med Watch Today to discuss how The Galaxy System has helped him and his team obtaining early diagnosis and treatment of lung cancer, and what it means for Valley patients. 

Learn more: https://hubs.ly/Q02DV3W40

#FirstandOnly #NoahMedical #GalaxySystem #LungCancer #Bronchoscopy #iiRAB #healthcare

Congratulations Dr. Molly Howsare Dr. Niraj Niraula Dr. Ghazaleh Bigdeli, Dr. Ryan Toolson, Dr. Ashlee Russo and entire your team at Mercy Health - St Elizabeth Youngstown Hospital for completing 50 cases! Thank you for your continued support being one of the FIRST and ONLY physicians in the U.S. to utilize The Galaxy System™ helping your patients obtain an early diagnosis!

#FirstandOnly #NoahMedical #GalaxySystem #LungCancer #Bronchoscopy #iiRAB #healthcare

Metric
Company Name	Noah Medical	Cyber Surgery	Zimmer Biomet
Symbol
MSH ID	COM:NOAHMED	COM:CYBER-SURGERY	EU:ZIMMERBIOMET
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical Devices and Technology	Medical Devices	Medical Devices
Country	US	ES	EU
Stage		Non Equity Assistance
Employee Count	344
Website	noahmed.com	cyber-surgery.com	zimmerbiomet.eu
LinkedIn	noahmed	cyber-surgery	zimmerbiomet
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	463	24.68K
Web Traffic Growth		-0.01
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:NOAHMED

Noah Medical

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue